Earnings Data
Report Date
Aug 10, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.29Last Year’s EPS
0.24Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call communicated strong top-line and margin progress driven by substantial acquisitional growth, robust Home Health & Hospice volume expansion, meaningful same-store margin improvements and active Senior Living M&A, backed by a strengthened leadership pipeline. At the same time, management emphasized near-term integration costs and operational disruption from EMR transitions, TSA expenses, labor and occupancy volatility tied to recent acquisitions, and modest liquidity constraints. Overall the positives (strong revenue and EBITDA growth, meaningful same-store improvement, admissions/census gains and disciplined M&A execution) outweigh the transitory integration and reimbursement headwinds, but the company remains cautious while completing large-scale integrations.Company Guidance
Strong Overall Revenue and Profit Growth
GAAP revenue of $285.4 million, up $75.5 million or 36% year-over-year; GAAP net income of $8.5 million, up 9.6%; adjusted net income of $11.5 million, up 19.8%; adjusted diluted EPS of $0.32, up $0.05 or 18.5%.
Adjusted EBITDA Expansion
Company adjusted EBITDA of $21.7 million, up $5.3 million or 32.6%; adjusted EBITDA prior to NCI of $23.5 million, up $6.4 million or 37.2% year-over-year.
Home Health & Hospice Segment Outperformance
Segment revenue $229.1 million, up $69.2 million or 43.3%; segment adjusted EBITDA $33.6 million, up $8.5 million or 33.7%; adjusted EBITDA prior to NCI $35.4 million, up $9.5 million or 36.6%.
Robust Volume and Same-Store Growth in Home Health
Total Home Health admissions 30,721 (+62.7% YoY); Medicare Home Health admissions 13,303 (+75.1% YoY); same-store total admissions +5.8% and same-store Medicare admissions +9.2% vs prior year quarter.
Strong Hospice Growth and Clinical Outcomes
Average daily census (ADC) for Hospice 5,199 (+37% YoY); same-store hospice ADC 3,952 (+10.2% YoY); positive clinical outcomes referenced (e.g., high hospice visit rates at highlighted agencies) and alignment with expected 2026 hospice rate proposal (+2.4%).
Same-Store Margin Improvements
Same-store segment adjusted EBITDA margin prior to NCI improved to 17.2%, a 110 basis point increase YoY, demonstrating operational leverage and productivity gains despite transition activity.
Senior Living Progress and Acquisitions
Senior Living revenue $56.3 million (+$6.3 million or 12.6% YoY); adjusted EBITDA $6.4 million (+30.6% YoY); segment adjusted EBITDA margin improved to 11.8% (+190 bps YoY); same-store occupancy 81% (+180 bps YoY). Completed several strategic Senior Living acquisitions (Lavender Lane and three communities post-quarter).
Leadership Development and Operating Model Scale
Significant leadership additions and promotions through 2025–2026 (leadership development program additions cited), with the company reporting a robust leadership pipeline (management count noted: 55 CEOs and 92 other C-level leaders in operations) to support growth and integration efforts.
Balance Sheet and Cash Flow Improvements
Net debt to adjusted EBITDA of 1.93x; total outstanding under credit facility $170.8 million; cash flows used in operations improved to -$3.4 million (a $17.8 million improvement vs prior year quarter).
DE:1ZU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:1ZU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | €26.40 | €28.40 | +7.58% |
Feb 25, 2026 | €26.40 | €27.60 | +4.55% |
Nov 05, 2025 | €21.60 | €21.80 | +0.93% |
Aug 06, 2025 | €18.50 | €18.80 | +1.62% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pennant Group Inc (DE:1ZU) report earnings?
Pennant Group Inc (DE:1ZU) is schdueled to report earning on Aug 10, 2026, After Close (Confirmed).
What is Pennant Group Inc (DE:1ZU) earnings time?
Pennant Group Inc (DE:1ZU) earnings time is at Aug 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Pennant Group Inc stock?
The P/E ratio of Pennant Group is N/A.
What is DE:1ZU EPS forecast?
DE:1ZU EPS forecast for the fiscal quarter 2026 (Q2) is 0.29.